title: Chronic intestinal pseudo-obstruction due to lymphocytic leiomyositis: is there a place for immunomodulatory therapy?
authors.forename: E
authors.initials: E
authors.lastname: Oton
authors.forename: V
authors.initials: V
authors.lastname: Moreira
authors.forename: C
authors.initials: C
authors.lastname: Redondo
authors.forename: A
authors.initials: A
authors.lastname: Lopez-San-Roman
authors.forename: J R
authors.initials: JR
authors.lastname: Foruny
authors.forename: G
authors.initials: G
authors.lastname: Plaza
authors.forename: E
authors.initials: E
authors.lastname: de Vicente
authors.forename: Y
authors.initials: Y
authors.lastname: Quijano
mesh_terms: D000293:Adolescent; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007418:Intestinal Pseudo-Obstruction / Q000276:immunology*; D007421:Intestine, Small / Q000276:immunology*; D008218:Lymphocytosis / Q000188:drug therapy*; D009130:Muscle, Smooth / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D011241:Prednisone